Delphia (USA) Inc. - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Delphia (USA) Inc. ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$54,568
+33.1%
17,717
+12.1%
0.07%
+139.3%
Q2 2022$41,000
-77.5%
15,799
-61.2%
0.03%
-79.4%
Q1 2022$182,00040,7330.14%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$7,605,0001.52%
Privium Fund Management (UK) Ltd 48,470$353,0000.38%
Pentwater Capital Management LP 4,967,227$36,211,0000.37%
J. Goldman & Co LP 301,391$2,197,0000.11%
Perceptive Advisors 787,745$5,743,0000.08%
KNOTT DAVID M 29,566$216,0000.08%
Virtus ETF Advisers LLC 23,082$168,0000.07%
Altium Capital Management LP 32,238$235,0000.06%
Advisory Services Network, LLC 268,290$1,956,0000.06%
MCF Advisors LLC 66,185$482,0000.05%
View complete list of POSEIDA THERAPEUTICS INC shareholders